About Novartis
Novartis is a company based in Stevenage (United Kingdom) founded in 2016 was acquired by Novartis in December 2021. It operates as a Direct-to-Consumer (D2C), and Professional Services. Novartis has raised $255.04 million across 5 funding rounds from investors including Novartis, T. Rowe Price and Sanofi. Novartis has completed 1 acquisition, including Orbit Biomedical. Novartis offers products and services including Zolgensma and Cosentyx. Novartis operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Stevenage, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novartis Ag
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novartis
Novartis offers a comprehensive portfolio of products and services, including Zolgensma and Cosentyx. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gene therapy for spinal muscular atrophy is provided.
Treatment for autoimmune diseases is offered by Novartis.
Unlock access to complete
Unlock access to complete
Scientific Team
9 people
Clinical Team
7 people
Leadership Team
7 people
Product Management Team
6 people
Software Development Team
4 people
Board Team
3 people
Operations Team
2 people
Human Resources and Administration
2 people
Unlock access to complete
Funding Insights of Novartis
Novartis has successfully raised a total of $255.04M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $40 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $40.0M
-
First Round
First Round
(01 Jun 2016)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - Novartis | Valuation | Sanofi |
|
| Mar, 2021 | Amount | Series C - Novartis | Valuation | Forbion | |
| Sep, 2019 | Amount | Series B - Novartis | Valuation | Syncona |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novartis
Novartis has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Novartis, T. Rowe Price and Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in life sciences and deep tech.
|
Founded Year | Domain | Location | |
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on lifescience and healthcare sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novartis
Novartis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Orbit Biomedical. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medical device for ophthalmic surgery is developed.
|
2018 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Novartis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novartis Comparisons
Competitors of Novartis
Novartis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novartis
Frequently Asked Questions about Novartis
When was Novartis founded?
Novartis was founded in 2016.
Where is Novartis located?
Novartis is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.
Is Novartis a funded company?
Novartis is a funded company, having raised a total of $255.04M across 5 funding rounds to date. The company's 1st funding round was a Series B of $60.8M, raised on Jun 01, 2016.
What does Novartis do?
Novartis is established as a global leader in innovative medicines, focusing on reimagining healthcare to improve and extend lives. The company operates in key therapeutic areas such as cardiovascular, renal, metabolic, immunology, neuroscience, and oncology. Solutions are developed to address significant disease burdens, reaching 296 million people worldwide. Research and development efforts are centered on breakthrough science, with a robust pipeline of transformative treatments. Novartis is committed to societal impact through access programs, environmental sustainability, and ethical standards.
Who are the top competitors of Novartis?
Novartis's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Novartis offer?
Novartis offers Zolgensma and Cosentyx.
How many acquisitions has Novartis made?
Novartis has made 1 acquisition, including Orbit Biomedical.
Who are Novartis's investors?
Novartis has 11 investors. Key investors include Novartis, T. Rowe Price, Sanofi, Syncona, and Fosun Pharmaceutical.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.